No Data
Sanxin Medical (300453.SZ) 2025 Annual Dividend Distribution: RMB 0.2 per share
Gelonghui, May 20 — Sanxin Medical (300453.SZ) announced its 2025 annual profit distribution implementation notice. The company’s 2025 annual general meeting of shareholders approved the following profit distribution plan: based on a total of 521,924,275 shares (after deducting 160,000 shares held in the company’s repurchase special securities account), a cash dividend of RMB 2.00 per 10 shares (tax inclusive) will be distributed to all shareholders. No bonus shares will be issued, and no capital reserve will be converted into share capital. The remaining undistributed profits will be carried forward to future years. The total cash dividend for this distribution is expected to amount to RMB 104,384,855 (tax inclusive). This equity distribution
Sanxin Medical (300453): Robust revenue growth over 25 years with continuous improvement in profitability.
Event: The company released its 2025 annual report, achieving operating revenue of 1.64 billion yuan (+9.31%), net profit attributable to shareholders of 265 million yuan (+16.51%), and non-recurring net profit attributable to shareholders of 242 million yuan (+15.15%).
Sanxin Medical (300453): Domestic centralized procurement policies tend to be moderate; new products and overseas markets drive growth.
Event Summary: The company released its annual report for 2025 and the first-quarter report for 2026. In 2025, revenue reached 1.64 billion yuan (yoy+9.3%), with a net profit attributable to shareholders of 265 million yuan.
Sanxin Medical: First Quarter Report for 2026
Sanxin Medical: Summary of the 2025 Annual Report
Sanxin Medical: 2025 Annual Report